These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38797195)

  • 1. Quality of Life in Older Adults With Stable Ischemic Heart Disease and Diabetes Mellitus: A Post Hoc Analysis of the BARI 2D Trial.
    Park DY; Jamil Y; Moumneh MB; Batchelor B W; Nanna MG; Damluji AA
    Am J Cardiol; 2024 Jul; 223():58-69. PubMed ID: 38797195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Chronic Kidney Disease on Outcomes of Myocardial Revascularization in Patients With Diabetes.
    Farkouh ME; Sidhu MS; Brooks MM; Vlachos H; Boden WE; Frye RL; Hartigan P; Siami FS; Bittner VA; Chaitman BR; Mancini GBJ; Fuster V
    J Am Coll Cardiol; 2019 Feb; 73(4):400-411. PubMed ID: 30704571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do Clinical Outcomes and Quality of Life Differ by the Number of Antianginals for Stable Ischemic Heart Disease? Insights from the BARI 2D Trial.
    Jamil Y; Park DY; Verde LM; Sherwood MW; Tehrani BN; Batchelor WB; Frampton J; Damluji AA; Nanna MG
    Am J Cardiol; 2024 Mar; 214():66-76. PubMed ID: 38160927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies in stable ischemic heart disease: lessons from the COURAGE and BARI-2D trials.
    Fernandez SF; Boden WE
    Curr Atheroscler Rep; 2010 Nov; 12(6):423-31. PubMed ID: 20845088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin provision therapy and mortality in older adults with diabetes mellitus and stable ischemic heart disease: Insights from BARI-2D trial.
    Damluji AA; Cohen ER; Moscucci M; Myerburg RJ; Cohen MG; Brooks MM; Rich MW; Forman DE
    Int J Cardiol; 2017 Aug; 241():35-40. PubMed ID: 28314486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes.
    Ramanathan K; Abel JG; Park JE; Fung A; Mathew V; Taylor CM; Mancini GBJ; Gao M; Ding L; Verma S; Humphries KH; Farkouh ME
    J Am Coll Cardiol; 2017 Dec; 70(24):2995-3006. PubMed ID: 29241487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors related to the selection of surgical versus percutaneous revascularization in diabetic patients with multivessel coronary artery disease in the BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) trial.
    Kim LJ; King SB; Kent K; Brooks MM; Kip KE; Abbott JD; Jacobs AK; Rihal C; Hueb WA; Alderman E; Sing IR; Attubato MJ; Feit F;
    JACC Cardiovasc Interv; 2009 May; 2(5):384-92. PubMed ID: 19463459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes).
    Tamis-Holland JE; Lu J; Korytkowski M; Magee M; Rogers WJ; Lopes N; Mighton L; Jacobs AK;
    J Am Coll Cardiol; 2013 Apr; 61(17):1767-76. PubMed ID: 23500245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease.
    Mancini GB; Farkouh ME; Brooks MM; Chaitman BR; Boden WE; Vlachos H; Hartigan PM; Siami FS; Sidhu MS; Bittner V; Frye R; Fuster V
    J Am Coll Cardiol; 2016 Sep; 68(10):985-95. PubMed ID: 27585501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.
    Mancini GBJ; Boden WE; Brooks MM; Vlachos H; Chaitman BR; Frye R; Bittner V; Hartigan PM; Dagenais GR
    Atherosclerosis; 2018 Oct; 277():186-194. PubMed ID: 29861270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
    J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prompt revascularization on outcomes in diabetic patients with stable ischemic heart disease and previous myocardial infarction in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Chung MJ; Novak E; Brown DL
    Coron Artery Dis; 2017 Jun; 28(4):301-306. PubMed ID: 28346285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revascularization versus medical therapy in patients aged 80 and older with stable ischemic heart disease.
    Phan DQ; Zadegan R; Lee MS
    J Am Geriatr Soc; 2021 Dec; 69(12):3457-3467. PubMed ID: 34363216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial.
    Abdallah MS; Wang K; Magnuson EA; Spertus JA; Farkouh ME; Fuster V; Cohen DJ;
    JAMA; 2013 Oct; 310(15):1581-90. PubMed ID: 24129463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction.
    Chaitman BR; Hardison RM; Adler D; Gebhart S; Grogan M; Ocampo S; Sopko G; Ramires JA; Schneider D; Frye RL;
    Circulation; 2009 Dec; 120(25):2529-40. PubMed ID: 19920001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health status after treatment for coronary artery disease and type 2 diabetes mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
    Brooks MM; Chung SC; Helmy T; Hillegass WB; Escobedo J; Melsop KA; Massaro EM; McBane RD; Hyde P; Hlatky MA;
    Circulation; 2010 Oct; 122(17):1690-9. PubMed ID: 20937978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of the BARI 2D and COURAGE trials: the evolving role of percutaneous coronary intervention.
    Holper EM; Addo T
    Coron Artery Dis; 2010 Nov; 21(7):397-401. PubMed ID: 20634692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial.
    Ikeno F; Brooks MM; Nakagawa K; Kim MK; Kaneda H; Mitsutake Y; Vlachos HA; Schwartz L; Frye RL; Kelsey SF; Waseda K; Hlatky MA;
    J Am Coll Cardiol; 2017 Jan; 69(4):395-403. PubMed ID: 28126156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial.
    Baron SJ; Chinnakondepalli K; Magnuson EA; Kandzari DE; Puskas JD; Ben-Yehuda O; van Es GA; Taggart DP; Morice MC; Lembo NJ; Brown WM; Banning A; Simonton CA; Kappetein AP; Sabik JF; Serruys PW; Stone GW; Cohen DJ;
    J Am Coll Cardiol; 2017 Dec; 70(25):3113-3122. PubMed ID: 29097293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.